Xencor Inc (XNCR) stock
XNCRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30194% above fair value
$34.39−0.11 (-0.32%)
Close on Nov 18, 2026Market cap $2.56BP/E –Yield –
Xencor enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Xencor's enterprise value was $3.03B on Nov 11, 2026, against $1.34B a year earlier. Over the last 5 years it ranged from $673.55M to $3.03B, with a median of $1.41B.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $3.03B | +153.2% |
| 2025 | Dec 31, 2025 | $1.20B | -31.5% |
| 2024 | Dec 31, 2024 | $1.75B | +41.5% |
| 2023 | Dec 29, 2023 | $1.24B | -17.9% |
| 2022 | Dec 30, 2022 | $1.50B | -34.7% |
| 2021 | Dec 31, 2021 | $2.30B | +17.7% |
| 2020 | Dec 31, 2020 | $1.96B | +39.4% |
| 2019 | Dec 31, 2019 | $1.40B | -20.3% |
| 2018 | Dec 31, 2018 | $1.76B | +114.9% |
| 2017 | Dec 29, 2017 | $819.31M | -16.3% |
| 2016 | Dec 30, 2016 | $978.47M | +111.0% |
| 2015 | Dec 31, 2015 | $463.83M | +4.9% |
| 2014 | Dec 31, 2014 | $442.11M | – |
| 2013 | Dec 31, 2013 | -$1.65M | – |
See a number that looks wrong?